Enzychem Lifesciences saw no growth in patent filings and highest growth of 0.49% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Enzychem Lifesciences’s patent filings and grants. Buy the databook here.
Enzychem Lifesciences has been focused on protecting inventions in Spain(ES) with one publication in Q2 2024
The Spain(ES) Patent Office dominates the patent grants with nearly 100% of grants. The Spain(ES) patent Office are among the top ten patent offices where Enzychem Lifesciences is filings its patents. Among the top granted patent authorities, Enzychem Lifesciences has 100% of its grants in Spain(ES).
For comprehensive analysis of Enzychem Lifesciences's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.